Abstract LB055: IBI3001: A potentially first-in-class site-specifically conjugated B7-H3/EGFR bispecific ADC for multiple solid tumors

医学 共轭体系 班级(哲学) 癌症研究 实体瘤 癌症 化学 内科学 计算机科学 有机化学 人工智能 聚合物
作者
Jian Guan,Xiao Zhang,Weiwei Wu,Lei Cao,Zhengguang Liao,Tianyu Zhu,Chentao Liu,Shuaixiang Zhou,Lu Jia,Ninghuan Li,Nana Luo,Ying Zhang,Dian Kang,Tiong Sun Chia,Bingliang Chen,Kaijie He
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (7_Supplement): LB055-LB055
标识
DOI:10.1158/1538-7445.am2024-lb055
摘要

Abstract B7-H3 and EGFR are both clinically validated TAAs in solid tumors. We previously demonstrated in IBI334 (B7-H3/EGFR bsAb) study that (1) B7-H3 and EGFR are co-expressed in multiple solid tumors; (2) B7-H3-aided EGFR signaling inhibition was significantly more potent than Zalutumumab (EGFR mAb) and Amivantamab (c-met/EGFR bsAb); and (3) IBI334 has favorable safety profile in cynomolgus monkey at 120 mg/kg/week. Building on this optimized bispecific antibody, we site-specifically conjugated IBI334 with Exatecan (drug-antibody-ratio = 4) using the clinically validated SyntecanE platform. The resulting bispecific ADC, IBI3001, has multiple mechanism of actions: (1) enhanced EGFR signaling blockage; (2) EGFR- and B7-H3-aided payload internalization and cytotoxicity; and (3) bystander killing effects of ADC. More importantly, the optimized B7-H3 arm not only enhances the EGFR signaling blockage but also reduces EGFR on-target toxicities. IBI3001 demonstrated potent in vitro cytotoxicity in all B7-H3LowEGFRLow, B7-H3HighEGFRLow, B7-H3LowEGFRHigh and B7-H3HighEGFRHigh cancer cells across multiple solid tumors, including lung cancer, colorectal cancer, pancreatic cancer, breast cancer, head and neck cancer, and stomach cancer. In addition, it had strong bystander effects, killing both EGFR+ B7-H3+ cancer cells and EGFR- B7-H3- cancer cells. All in vitro studies were further validated in vivo with robust tumor growth inhibition in NCI-H508 (colorectal cancer), JIMT-1 (breast cancer), BxPC3 (pancreatic cancer) and NCI-1975 (lung cancer) xenograft models. IBI3001 has a favorable PK profile in BALB/c mice with the half-life at 282 hours, and is well-tolerated in cynomolgus monkeys up to 90 mg/kg/week. In conclusion, IBI3001 is a novel bispecific ADC that demonstrated strong anti-tumor efficacy cross multiple solid tumors, and has excellent PK and safety profile. Citation Format: Jian Guan, Xiao Zhang, Weiwei Wu, Lei Cao, Zhengguang Liao, Tianyu Zhu, Chentao Liu, Shuaixiang Zhou, Jia Lu, Ninghuan Li, Nana Luo, Ying Zhang, Kang Dian, Tiong Sun Chia, Bingliang Chen, Kaijie He. IBI3001: A potentially first-in-class site-specifically conjugated B7-H3/EGFR bispecific ADC for multiple solid tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl):Abstract nr LB055.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形曼青应助彳亍采纳,获得10
刚刚
SciGPT应助终陌采纳,获得10
1秒前
1秒前
深耕完成签到,获得积分10
2秒前
2秒前
2秒前
隐形曼青应助猫不吃狗粮采纳,获得10
4秒前
lalala完成签到,获得积分10
5秒前
小奋斗发布了新的文献求助30
5秒前
zly完成签到,获得积分10
5秒前
xiaotianshi发布了新的文献求助10
6秒前
6秒前
12发布了新的文献求助20
7秒前
彳亍1117应助hym采纳,获得10
7秒前
8秒前
8秒前
矫仁瑞发布了新的文献求助10
8秒前
小二郎应助李老头采纳,获得10
9秒前
思源应助周女士采纳,获得10
9秒前
9秒前
xx完成签到,获得积分10
9秒前
10秒前
bjjtdx1997完成签到,获得积分10
10秒前
OxO完成签到,获得积分10
10秒前
璟晔发布了新的文献求助50
11秒前
Jasper应助刘金泽采纳,获得10
11秒前
11秒前
CC完成签到,获得积分10
11秒前
小智完成签到,获得积分10
11秒前
11秒前
糖不太甜发布了新的文献求助10
12秒前
JoJo发布了新的文献求助10
12秒前
最初呢发布了新的文献求助20
12秒前
12秒前
Akim应助危机采纳,获得10
12秒前
13秒前
张朝程完成签到,获得积分10
14秒前
儒雅无血发布了新的文献求助10
15秒前
骑士完成签到,获得积分10
15秒前
个性的紫菜应助胜天半子采纳,获得10
15秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3160558
求助须知:如何正确求助?哪些是违规求助? 2811730
关于积分的说明 7893251
捐赠科研通 2470605
什么是DOI,文献DOI怎么找? 1315658
科研通“疑难数据库(出版商)”最低求助积分说明 630920
版权声明 602042